Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
508 studies found for:    "Lupus Erythematosus, Systemic"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Systemic Lupus Erythematous and Heart Conduction Disorders
Conditions: Lupus Erythematosus, Systemic;   Atrioventricular Block;   Sudden Death
Intervention: Other: No intervention
2 Not yet recruiting Using the Cholinergic Anit-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain
Conditions: Lupus Erythematosus, Systemic;   Musculoskeletal Pain
Interventions: Device: Vagus nerve stimulation;   Device: Sham vagus nerve stimulation
3 Completed Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome
Conditions: Lupus Erythematosus, Systemic;   Sjogren's Syndrome
Intervention: Drug: Dehydroepiandrosterone
4 Terminated Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE)
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: epratuzumab
5 Completed Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077)
Conditions: Lupus Erythematosus, Systemic;   Lupus Nephritis
Interventions: Drug: CTLA4-IgG4m (RG2077);   Drug: Cyclophosphamide
6 Terminated Physical Therapy for Systemic Lupus Erythematosus (SLE)
Conditions: Lupus Erythematosus, Systemic;   SLE
Intervention: Behavioral: Physical Therapy or Relaxation Therapy
7 Completed Anti-CD20 in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: Rituximab
8 Unknown  Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Systemic;   Arthritis, Rheumatoid
Intervention:
9 Recruiting MSC2364447C Phase 1b in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: MSC2364447C;   Drug: Placebo
10 Not yet recruiting Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi)
Condition: Lupus Erythematosus, Systemic
Intervention: Other: Qi Gong
11 Completed
Has Results
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: fludarabine phosphate;   Drug: cyclophosphamide;   Biological: Rituxan (rituximab);   Biological: filgrastim;   Drug: methylprednisolone;   Other: immunologic technique;   Other: laboratory biomarker analysis;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: Diphenhydramine;   Drug: Mesna
12 Unknown  Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Procedure: Hematopoietic Cell Transplantation
13 Completed
Has Results
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions
Conditions: Lupus Erythematosus, Discoid;   Lupus Erythematosus, Systemic
Interventions: Drug: R932333;   Drug: Placebo
14 Completed A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus
Conditions: Lupus Erythematosus, Cutaneous;   Lupus Erythematosus, Systemic
Interventions: Drug: 1 mg/kg CNTO 136;   Drug: 4 mg/kg CNTO 136;   Drug: 10 mg/kg CNTO 136;   Drug: Placebo
15 Active, not recruiting Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification
Conditions: Osteoporosis;   Lupus Erythematosus, Systemic
Interventions: Biological: RANKL/OPG ratio;   Device: bone densitometry;   Device: fan beam CT scan;   Device: Doppler ultrasound
16 Unknown  Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
17 Completed Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis
Conditions: Lupus Nephritis;   Lupus Erythematosus, Systemic
Intervention: Drug: tacrolimus
18 Active, not recruiting Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention:
19 Completed Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Intervention: Drug: SBI-087
20 Active, not recruiting Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus
Condition: Lupus Erythematosus, Systemic
Interventions: Drug: Atacicept 75 milligram (mg);   Drug: Atacicept 150 mg;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years